🔴 Lantern Pharma is trading 5% down in pre-market

Lantern Pharma is trading at $0.77, with a -5.22% change in the October 12 pre-market; no clear company-specific catalyst was identified.

• The company’s latest posted press release is dated September 30.
• Recent Taiwan trial-site approvals and an October 15 investor presentation announcement are positive updates, not reported explanations for the decline.
• Lantern Pharma had also been trending lower in recent sessions. Major-index moves were modest and mixed, and the evidence does not establish broader market sentiment as the explanation.